CMS Open Payments · Program Year 2024
Auxano Medical LLC
Auxano Medical LLC reported $8,832.33 across General Payments, Research, and Ownership to 10 physicians and teaching hospitals across 10 transactions.
- $8.8K Below-median payer
- All-tracks total
- 10 Below-median volume
- Transactions
- 10 Below-median reach
- Recipients
- #1656
- of 1,925 companies
Auxano Medical LLC reported $8,832.33 across all CMS Open Payments tracks (General + Research + Ownership) to 10 physicians and teaching hospitals in Program Year 2024 - ranking #1656 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $8,832.33, averaging $883.23 per recipient.
Auxano Medical LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
13/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer auxano-medical-llc Auxano Medical LLC
$8.8K · #1656/1,925 · 0.0% industry · PY2024
- TOT $8.8K
- RANK #1656
- SHARE 0.0%
- TXN 10
- RCP 10
- CAT 2
- GEN $8.8K
- TOP1 92.4%
- PY 2024
Volume peers
Nearest volume peer: Avvisto Therapeutics, LLC ($8.9K)
Auxano Medical LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Auxano Medical LLC
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Auxano Medical LLC that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $8.0K, accounting for 90.6% of this company's General Payments and 2 transactions.
General Payment Breakdown by Type
"Consulting Fee" leads Auxano Medical LLC's 2-category general-payment breakdown at $8.0K, 90.6% of the reported total.
How Auxano Medical LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $8.0K | 2 | 90.6% |
| Food and Beverage | $832.33 | 8 | 9.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $8,756.56 (99.1%) of $8,832.33 in this company's General Payments records across 7 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Auxano Medical LLC
The five named recipients with the highest reported General Payments from this company
- 1
Keith Jacobson
$8,157.79 across 3 reported transactions
- 2
Thomas Savage
$157.79 across 1 reported transactions
- 3
Kira Cramer
$157.79 across 1 reported transactions
- 4
Kevin Blue
$157.79 across 1 reported transactions
- 5
Brian Gallagher
$125.40 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Auxano Medical LLC ranks #1656 of 1,925 by total payments (bottom 14% by spend) but is notably more concentrated than that alone would suggest -- #189 of 1,838 by HHI (top 10% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Elucid Bioimaging Inc : $130.1K total payments, HHI 8681
- Biolase MG LLC : $11.5K total payments, HHI 8681
- Xiros Inc : $3.4K total payments, HHI 8644
- Emmaus Medical, Inc. : $197.9K total payments, HHI 8631
- OrthoPediatrics Canada ULC : $104.0K total payments, HHI 8624
- Sequoia Surgical Distributors, LLC : $65.8K total payments, HHI 8574
- Auxano Medical LLC (this company) : $8.8K total payments, HHI 8543
- Swan Valley Medical Incorporated : $65.3K total payments, HHI 8507
- Veryan Medical Incorporated : $359.2K total payments, HHI 8362
- Poriferous LLC : $7.6K total payments, HHI 8281
- Myocardial Solutions, Inc. : $4.2K total payments, HHI 8121
- Immucor, Inc. : $601.94 total payments, HHI 8069
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Auxano Medical LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Auxano Medical LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Auxano Medical LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Digestive Care, Inc.
Prolaio, Inc.
Darco International, Inc.
Biocartis US, Inc
G21 Srl
Put this to use
Auxano Medical LLC ranks #1656 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Auxano Medical LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.